The board of directors of AstraZeneca Pharma India Limited at its Meeting held on December 14, 2022, approved the Resignation of Mr. Gagandeep Singh Bedi from the Office as Director of the Company with effect from the closing of business hours on December 31, 2022. Reason for Resignation: Consequent to transfer to a new position within AstraZeneca Group.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6,087 INR | -1.23% | -5.50% | +10.27% |
May. 28 | Astrazeneca Pharma India's Net Profit Rises in Fiscal Q4 | MT |
May. 27 | AstraZeneca Pharma India Limited Announces Resignation of Ankush Nandra as Non-Executive Director | CI |
1st Jan change | Capi. | |
---|---|---|
+10.27% | 1.85B | |
+40.73% | 739B | |
+31.60% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+14.58% | 240B | |
+9.44% | 210B | |
-4.91% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- ASTRAZEN Stock
- News AstraZeneca Pharma India Limited
- Astrazeneca Pharma India Limited Announces Resignation of Gagandeep Singh Bedi as Director, Effective December 31, 2022